T. Andrew Crockett

2023

In 2023, T. Andrew Crockett earned a total compensation of $3.6M as Chief Executive Officer at Carbylan Therapeutics, a 44% decrease compared to previous year.

Compensation breakdown

Bonus$266,805
Option Awards$454,610
Salary$635,200
Stock Awards$2,265,714
Other$12,603
Total$3,634,983

Crockett received $2.3M in stock awards, accounting for 62% of the total pay in 2023.

Crockett also received $266.8K in bonus, $454.6K in option awards, $635.2K in salary and $12.6K in other compensation.

Rankings

In 2023, T. Andrew Crockett's compensation ranked 103rd out of 1,352 executives tracked by ExecPay. In other words, Crockett earned more than 92.4% of executives.

ClassificationRankingPercentile
All
103
out of 1,352
92nd
Division
Manufacturing
54
out of 666
92nd
Major group
Chemicals And Allied Products
30
out of 320
91st
Industry group
Drugs
29
out of 296
90th
Industry
Pharmaceutical Preparations
18
out of 223
92nd
Source: SEC filing on August 14, 2023.

Crockett's colleagues

We found two more compensation records of executives who worked with T. Andrew Crockett at Carbylan Therapeutics in 2023.

2023

Benjamin Palleiko

Carbylan Therapeutics

Chief Financial Officer

2023

Christopher Yea

Carbylan Therapeutics

Chief Development Officer

News

You may also like